drugset / Trial / NCT00235001

Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

NCT00235001

Phase 4 Completed 120 enrolled Abbott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)

Timeline

Start
2004-06
Primary completion
2006-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Verapamil Other / unclassified 2 mg
Subject trandolapril Small molecule 180 mg

Indications